Correlation Between Novozymes A/S and Sherwin Williams

Can any of the company-specific risk be diversified away by investing in both Novozymes A/S and Sherwin Williams at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novozymes A/S and Sherwin Williams into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Novozymes AS B and Sherwin Williams Co, you can compare the effects of market volatilities on Novozymes A/S and Sherwin Williams and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novozymes A/S with a short position of Sherwin Williams. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novozymes A/S and Sherwin Williams.

Diversification Opportunities for Novozymes A/S and Sherwin Williams

0.13

Correlation Coefficient

Novozymes A/S  Sherwin Williams

Average diversification

The 3 months correlation between Novozymes and Sherwin is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Novozymes AS B and Sherwin Williams Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sherwin Williams and Novozymes A/S is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novozymes AS B are associated (or correlated) with Sherwin Williams. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sherwin Williams has no effect on the direction of Novozymes A/S i.e., Novozymes A/S and Sherwin Williams go up and down completely randomly.

Pair Corralation between Novozymes A/S and Sherwin Williams

Assuming the 90 days horizon Novozymes AS B is expected to generate 2.2 times more return on investment than Sherwin Williams. However, Novozymes A/S is 2.2 times more volatile than Sherwin Williams Co. It trades about 0.05 of its potential returns per unit of risk. Sherwin Williams Co is currently generating about 0.01 per unit of risk. If you would invest  5,551  in Novozymes AS B on December 29, 2024 and sell it today you would earn a total of  316.00  from holding Novozymes AS B or generate 5.69% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Novozymes AS B  vs.  Sherwin Williams Co

Novozymes AS B

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Novozymes AS B are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak primary indicators, Novozymes A/S may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Sherwin Williams

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Sherwin Williams Co are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable technical indicators, Sherwin Williams is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Novozymes A/S and Sherwin Williams

The main advantage of trading using opposite Novozymes A/S and Sherwin Williams positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novozymes A/S position performs unexpectedly, Sherwin Williams can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sherwin Williams will offset losses from the drop in Sherwin Williams' long position.

The idea behind Novozymes AS B and Sherwin Williams Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.